An analgesia circuit activated by cannabinoids
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Although many anecdotal reports indicate that marijuana and its active constituent, delta-9-tetrahydrocannabinol (delta-9-THC), may reduce pain sensation, studies of humans have produced inconsistent results. In animal studies, the apparent pain-suppressing effects of delta-9-THC and other cannabinoid drugs are confounded by motor deficits. Here we show that a brainstem circuit that contributes to the pain-suppressing effects of morphine is also required for the analgesic effects of cannabinoids. Inactivation of the rostral ventromedial medulla (RVM) prevents the analgesia but not the motor deficits produced by systemically administered cannabinoids. Furthermore, cannabinoids produce analgesia by modulating RVM neuronal activity in a manner similar to, but pharmacologically dissociable from, that of morphine. We also show that endogenous cannabinoids tonically regulate pain thresholds in part through the modulation of RVM neuronal activity. These results show that analgesia produced by cannabinoids and opioids involves similar brainstem circuitry and that cannabinoids are indeed centrally acting analgesics with a new mechanism of action.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“cannabinoids produce analgesia either in animal models of pain (both acute pain and tonic pain) or in clinical painful conditions (for reviews see: 161,221), and endogenous cannabinoids are tonically released to participate in the control of basal nociceptive threshold (137).”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [137]
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Endogenous Pain Control Systems: Brainstem Spinal Pathways and Endorphin Circuitry
Basbaum, A. I., & Fields, H. L. (1984) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.07.030184.001521 · Cited by 2,687
Self-citationSR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi-Carmona, M., Barth, F., Héaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Néliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,757
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586
A second endogenous cannabinoid that modulates long-term potentiation
Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496
Cadas, H., di Tomaso, E., & Piomelli, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-04-01226.1997 · Cited by 396
The analgesic properties of delta‐9‐tetrahydrocannabinol and codeine
Noyes, R., Brunk, S. F., Avery, D. H., & Canter, A. (1975) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt197518184 · Cited by 378
Research works printed but not linked: 1
- Buxbaum, D., Sanders-Bush, E. & Efron, D. Analgesic activity of tetrahydrocannabinol (THC) in the rat and mouse. Fed. Proc. 28, 735 (1969).
Cited by
Millan, M. J. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00009-6 · Cited by 3,035
“However, the degree of tonic influence of supraspinal populations of CB1 receptors upon nociception under resting conditions remains controversial (Meng et al., 1998; Strangman et al., 1998; Ledent et al., 1999; Bridges et al., 2001; Pertwee, 2001).”
BackgroundThe Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
“…nervous system (Martin et al., 1993; Hohmann et al., 1995, 1998, 1999; Martin et al., 1995, 1996, 1998, 1999a,b; Richardson et al., 1997, 1998a,b; Meng et al., 1998; Strangman et al., 1998; Hohmann and Walker, 1999; Fox et al., 2001), spinal cord (Yaksh, 1981; Lichtman and Martin, 1991a,b; Welch…”
The molecular logic of endocannabinoid signalling
Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957
Role of Endogenous Cannabinoids in Synaptic Signaling
FREUND, T. F., KATONA, I., & PIOMELLI, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,574
Endocannabinoid Signaling in the Brain
Wilson, R. I., & Nicoll, R. A. (2002) · Science · doi:10.1126/science.1063545 · Cited by 1,260
Ossipov, M. H., Dussor, G. O., & Porreca, F. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43766 · Cited by 1,159
Descending control of nociception: Specificity, recruitment and plasticity
Heinricher, M. M., Tavares, I., Leith, J. L., & Lumb, B. M. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.12.009 · Cited by 949
“However, one possibility is that NEUTRAL-cells are recruited to become ON-or OFF-cells during development of chronic pain states (Miki et al., 2002).”
BackgroundAn endocannabinoid mechanism for stress-induced analgesia
Hohmann, A. G., Suplita, R. L., Bolton, N. M., Neely, M. H., Fegley, D., Mangieri, R., Krey, J. F., Michael Walker, J., Holmes, P. V., Crystal, J. D., et al. (2005) · Nature · doi:10.1038/nature03658 · Cited by 778
Central nervous system mechanisms of pain modulation
Fields, H. L., Basbaum, A. I., & Heinricher, M. M. (2006) · Wall and Melzack's Textbook of Pain · doi:10.1016/b0-443-07287-6/50012-6 · Cited by 757
Self-citationCannabinoid receptors and pain
Pertwee, R. G. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00031-9 · Cited by 741
Iversen, L. (2003) · Brain · doi:10.1093/brain/awg143 · Cited by 732
“However, measurements of endocannabinoids have yielded variable results, and a strict correlation would not be expected for ligands that are only produced on demand.”
BackgroundButler, R. K., & Finn, D. P. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.04.003 · Cited by 714
“, 1999) and a role for GABA in mediating the antinociceptive effects of cannabinoids (Meng et al., 1998; for review see Rea et al., 2007).”
BackgroundParacetamol: New Vistas of an Old Drug
Bertolini, A., Ferrari, A., Ottani, A., Guerzoni, S., Tacchi, R., & Leone, S. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00250.x · Cited by 674
“Indeed, cannabinoids produce analgesia either in animal models of pain (both acute pain and tonic pain) or in clinical painful conditions (for reviews see: 161,221), and endogenous cannabinoids are tonically released to participate in the control of basal nociceptive threshold (137).”
BackgroundCannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors
Agarwal, N., Pacher, P., Tegeder, I., Amaya, F., Constantin, C. E., Brenner, G. J., Rubino, T., Michalski, C. W., Marsicano, G., Monory, K., et al. (2007) · Nature Neuroscience · doi:10.1038/nn1916 · Cited by 571
The Antidepressive Effects of Exercise: A Meta-Analysis of Randomized Trials
Rethorst, C. D., Wipfli, B. M., & Landers, D. M. (2009) · Sports Medicine · doi:10.2165/00007256-200939060-00004 · Cited by 541
Diencephalic and brainstem mechanisms in migraine
Akerman, S., Holland, P. R., & Goadsby, P. J. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3057 · Cited by 532
Brain mechanisms of pain affect and pain modulation
Rainville, P. (2002) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(02)00313-6 · Cited by 634
“Recent work also suggests that the amygdala is involved in opioid- and cannabinoiddependent pain modulation, possibly through descending modulatory processes [17,18].”
BackgroundThe Endocannabinoid System and Pain
Guindon, J., & Hohmann, A. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824660 · Cited by 476
“Endocannabinoid-mediated stress-induced analgesia is also enhanced in a CB1-dependent manner by intra-RVM administration of a FAAH inhibitor, administered at doses that do not alter the basal nociceptive threshold [138].”
BackgroundInfluentialSmoked cannabis for chronic neuropathic pain: a randomized controlled trial
Ware, M. A., Wang, T., Shapiro, S., Robinson, A., Ducruet, T., Huynh, T., Gamsa, A., Bennett, G. J., & Collet, J.-P. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.091414 · Cited by 450
“An endogenous pain-processing system has been identified, mediated by endogenous cannabinoid ligands acting on specific cannabinoid receptors.(6) These findings, coupled with anecdotal evidence of the analgesic effects of smoked cannabis,(7) support a reconsideration of cannabinoid agents as analgesics.”
BackgroundZhang, J., Hoffert, C., Vu, H. K., Groblewski, T., Ahmad, S., & O'Donnell, D. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02704.x · Cited by 419
The neurobiology and evolution of cannabinoid signalling
Elphick, M. R., & Egertova, M. (2001) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2000.0787 · Cited by 417
Dietrich, A., & McDaniel, W. F. (2004) · British Journal of Sports Medicine · doi:10.1136/bjsm.2004.011718 · Cited by 410
“14 30 35 Analgesia is mediated in part by the endogenous opioid system.”
BackgroundPharmacological and biochemical interactions between opioids and cannabinoids
Manzanares, J., Corchero, J., Romero, J., Fernández-Ruiz, J. J., Ramos, J. A., & Fuentes, J. A. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01339-5 · Cited by 392
Cannabinoids and Pain: New Insights From Old Molecules
Vučković, S., Srebro, D., Vujović, K. S., Vučetić, Č., & Prostran, M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01259 · Cited by 376
“The effect of THC and other cannabinoids acting at CB1 receptors on motor activity in animals may easily be misinterpreted as pain-suppressing behavior (Meng et al., 1998).”
BackgroundThe presence of Cholinomimetic and calcium channel antagonist constituents in Piper betle Linn.
Gilani, A. H., Aziz, N., Khurram, I. M., Rao, Z. A., & Ali, N. K. (2000) · Phytotherapy Research · doi:10.1002/1099-1573(200009)14:6<436::aid-ptr620>3.0.co;2-c · Cited by 35
Naturally occurring antinociceptive substances from plants
Calixto, J. B., Beirith, A., Ferreira, J., Santos, A. R. S., Filho, V. C., & Yunes, R. A. (2000) · Phytotherapy Research · doi:10.1002/1099-1573(200009)14:6<401::aid-ptr762>3.0.co;2-h · Cited by 339
Jennings, E. M., Okine, B. N., Roche, M., & Finn, D. P. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.06.003 · Cited by 318
“Direct injection of cannabinoid receptor agonists into the RVM, amygdala, thalamus or PAG results in anti-nociception (Finn et al., 2003; Martin et al., 1999; Meng et al., 1998).”
BackgroundSynergistic interactions between cannabinoid and opioid analgesics
Cichewicz, D. L. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.09.038 · Cited by 305
“In fact, Meng and colleagues demonstrate that analgesia produced by cannabinoids and opioids involve similar brainstem circuitry through modulation of rostal ventromedial medulla neuronal activity (Meng et al., 1998).”
BackgroundKourounakis, A. P., Xanthopoulos, D., & Tzara, A. (2020) · Medicinal Research Reviews · doi:10.1002/med.21634 · Cited by 294
Descending modulation of pain: the GABA disinhibition hypothesis of analgesia
Lau, B. K., & Vaughan, C. W. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.07.010 · Cited by 297
“This hypothesis has since been adopted to include other analgesic agents, such as cannabinoids [10].”
BackgroundMaione, S., Bisogno, T., de Novellis, V., Palazzo, E., Cristino, L., Valenti, M., Petrosino, S., Guglielmotti, V., Rossi, F., & Marzo, V. D. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.093286 · Cited by 294
“This latter mechanism, together with inhibition of GABA release from RVM interneurons, underlies those antinociceptive effects of CB1 receptor activation that are common to opiate-induced analgesia in these midbrain and medulla areas (Meng et al., 1998; Meng and Johansen, 2004).”
BackgroundInfluentialManzanares, J., Julian, M., & Carrascosa, A. (2006) · Current Neuropharmacology · doi:10.2174/157015906778019527 · Cited by 287
“Temporary inactivation of neural activity in the RVM in rat brainstem circumvents the analgesic effects of systemically administered cannabinoids, while leaving motor activity effects untouched [104].”
The neurobiology of individual differences in complex behavioral traits
Hariri, A. R. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135335 · Cited by 273
“Such eCB signaling has emerged as a potent modulator of neural circuitries mediating both basic physiological (Calignano et al. 1998, Meng et al. 1998) and advanced behavioral responses (Maldonado et al. 2006, Scherma et al. 2008, Viveros et al. 2005).”
BackgroundThe analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors
Ottani, A., Leone, S., Sandrini, M., Ferrari, A., & Bertolini, A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.015 · Cited by 279
Calejesan, A. A., Kim, S. J., & Zhuo, M. (2000) · European Journal of Pain · doi:10.1053/eujp.1999.0158 · Cited by 269
“Descending inhibitory influences are believed to be important for the analgesic effects of opioids and cannabinoids as well as stimulation-produced analgesia (Basbaum & Fields, 1984; Fields et al., 1988; 1991; Meng et al., 1998; Mitchell et al., 1998).”
BackgroundCannabinoid CB1 Receptor Expression in Rat Spinal Cord
Farquhar-Smith, W. P., Egertová, M., Bradbury, E. J., McMahon, S. B., Rice, A. S. C., & Elphick, M. R. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0844 · Cited by 268
Raichlen, D. A., Foster, A. D., Gerdeman, G. L., Seillier, A., & Giuffrida, A. (2012) · Journal of Experimental Biology · doi:10.1242/jeb.063677 · Cited by 265
“In addition to acting at peripheral sites, CB receptors are found at central sites implicated in pain modulation such as the dorsal horn of the lumbar spinal cord and the rostral ventromedial medulla of the brainstem (Hohmann et al., 1999; Meng et al., 1998), suggesting that circulating eCBs may also lead to a central…”
BackgroundHariri, A. R., Gorka, A., Hyde, L. W., Kimak, M., Halder, I., Ducci, F., Ferrell, R. E., Goldman, D., & Manuck, S. B. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.047 · Cited by 248
“Such endogenous cannabinoid or endocannabinoid (eCB) signaling has emerged as a potent modulator of neural circuitries mediating both basic physiological (2; 3) and advanced behavioral responses (4–6).”
Potential Analgesic Mechanisms of Acetaminophen
Smith, H. (2009) · Pain Physician · doi:10.36076/ppj.2009/12/269 · Cited by 245
Vaughan, C. W., Connor, M., Bagley, E. E., & Christie, M. J. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23200-4 · Cited by 241
“These findings indicate that cannabinoids and m-opioids are likely to produce analgesia within the PAG by distinct, but partially overlapping, disinhibitory mechanisms. at A SPE T Journals on July 15, 2017 m olpharm .aspetjournals.org D ow nloaded from In this study, it was demonstrated that cannabinoid agonists act v…”
InfluentialEndocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia
Mallet, C., Daulhac, L., Bonnefont, J., Ledent, C., Etienne, M., Chapuy, E., Libert, F., & Eschalier, A. (2008) · Pain · doi:10.1016/j.pain.2008.03.030 · Cited by 223
“Similarly, activation of this system by exogenous ligands for cannabinoid (particularly CB1) receptors induces antinociception in various acute pain tests in rodents [16,24,33] but also in several animal models of chronic pain [17].”
BackgroundThe endocannabinoid nervous system
Porter, A. C., & Felder, C. C. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00130-9 · Cited by 227
“Reports indicate that cannabinoids can act independently and/or in concert with opioids to modulate the pain response (Welch & Stevens, 1992; Smith et al., 1994; Meng et al., 1998).”
BackgroundCannabinoid signaling in glial cells
Stella, N. (2004) · Glia · doi:10.1002/glia.20084 · Cited by 219
“THC interacts with CB receptors expressed by neurons and induces psychotropic effects (Huestis et al., 2001), memory impairment (Hampson and Deadwyler, 2000), and analgesia (Meng et al., 1998), as well as many other less studied effects.”
BackgroundNew perspectives on enigmatic vanilloid receptors
Szallasi, A., & Di Marzo, V. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01630-1 · Cited by 216
Endocannabinoid mechanisms of pain modulation
Hohmann, A. G., & Suplita, R. L. (2006) · The AAPS Journal · doi:10.1208/aapsj080479 · Cited by 212
Adverse effects of cannabis and cannabinoids
Ashton, C. H. (1999) · British Journal of Anaesthesia · doi:10.1093/bja/83.4.637 · Cited by 214
Medicinal Use of Cannabis: History and Current Status
Kalant, H. (2001) · Pain Research and Management · doi:10.1155/2001/469629 · Cited by 212
Cannabis use in HIV for pain and other medical symptoms
Woolridge, E., Barton, S., Samuel, J., Osorio, J., Dougherty, A., & Holdcroft, A. (2005) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2004.07.011 · Cited by 208
Baron, E. P. (2015) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.12570 · Cited by 206
The endogenous cannabinoid system and its role in nociceptive behavior
Cravatt, B. F., & Lichtman, A. H. (2004) · Journal of Neurobiology · doi:10.1002/neu.20080 · Cited by 203
“…that CB1 receptor agonists modulate both spinal (Hohmann et al., 1995, 1998; Strangman et al., 1998; Strangman and Walker, 1999; Drew et al., 2000; Chapman, 2001; Kelly and Chapman, 2001) and supraspinal (Martin et al., 1996; Meng et al., 1998) neural circuits that transmit nociceptive signals.”
BackgroundCannabinoids and Pain: Sites and Mechanisms of Action
Starowicz, K., & Finn, D. P. (2017) · Advances in Pharmacology · doi:10.1016/bs.apha.2017.05.003 · Cited by 193
Cannabinoid receptors undergo axonal flow in sensory nerves
Hohmann, A. G., & Herkenham, M. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00220-1 · Cited by 194
Cannabis use for chronic non-cancer pain: results of a prospective survey
Ware, M. A., Doyle, C. R., Woods, R., Lynch, M. E., & Clark, A. J. (2003) · Pain · doi:10.1016/s0304-3959(02)00400-1 · Cited by 185
“Cannabinoids appear to be components of a neural circuit which may play a role in modulating pain (Meng et al., 1998), supporting earlier observations, and providing some rationale for the potential clinical use of cannabis and related medicines.”
BackgroundResultInfluentialLack of analgesic efficacy of oral δ-9-tetrahydrocannabinol in postoperative pain
Buggy, D. J., Toogood, L., Maric, S., Sharpe, P., Lambert, D. G., & Rowbotham, D. J. (2003) · Pain · doi:10.1016/s0304-3959(03)00331-2 · Cited by 184
“There is significant evidence that cannabinoids have antinociceptive properties in animals (Martin and Lichtman, 1998) and the role of cannabinoid receptors in the modulation of pain has been described (Meng et al., 1998).”
BackgroundExercise-induced endocannabinoid signaling is modulated by intensity
Raichlen, D. A., Foster, A. D., Seillier, A., Giuffrida, A., & Gerdeman, G. L. (2013) · European Journal of Applied Physiology · doi:10.1007/s00421-012-2495-5 · Cited by 181
“…mitigate chronic and acute pain at both central and peripheral sites (Agarwal et al. 2007; Gerdeman 2008; Hohmann and Suplita 2006; Hohmann et al. 1999, 2005; Ibrahim et al. 2003; Piomelli 2003; Richardson 2000; Meng et al. 1998) and therefore likely play a role in exercise-induced analgesia.”
BackgroundCannabinoid Mechanisms of Pain Suppression
Walker, J. M., & Hohmann, A. G. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_17 · Cited by 176
Walker, J. M., & Huang, S. M. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00252-8 · Cited by 176
Maione, S., Piscitelli, F., Gatta, L., Vita, D., De Petrocellis, L., Palazzo, E., de Novellis, V., & Di Marzo, V. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01063.x · Cited by 175
“and adenosine A1 receptor agonists, have been found to reduce ON cell and stimulate OFF cell activity after intra-PAG injections (Fields et al., 1983; Heinricher and Tortorici, 1994; Meng et al., 1998; Fields, 2004; de Novellis et al., 2005; Maione et al., 2007).”
BackgroundInfluentialCannabinoids: a real prospect for pain relief
Iversen, L. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00120-5 · Cited by 162
Spinal cannabinoids are anti-allodynic in rats with persistent inflammation
Martin, W. J., Loo, C. M., & Basbaum, A. I. (1999) · Pain · doi:10.1016/s0304-3959(99)00045-7 · Cited by 161
“Furthermore, these antinociceptive actions are associated with cannabinoid-induced modulation of noxiousstimulus induced activity of neurons in the spinal cord (Hohmann et al., 1995), brainstem (Meng et al., 1998) and thalamus (Martin et al., 1996).”
BackgroundSelf-citationHohmann, A. G. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00154-8 · Cited by 159
Neural Basis for the Hyperalgesic Action of Cholecystokinin in the Rostral Ventromedial Medulla
Heinricher, M. M., & Neubert, M. J. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00411.2004 · Cited by 168
“…agonists, neurotensin , and cannabinoids, as well as block of endogenous excitatory amino acid inputs by N-methyl-D-aspartate (NMDA) and non-NMDA receptor antagonists (Harasawa et al. 2000; Heinricher and McGaraughty 1998; Heinricher et al. 1988, 1992; Meng et al. 1998; Neubert et al. 2004).”
Morisset, V., & Urbán, L. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.86.1.40 · Cited by 157
“…models of acute and chronic pain (Calignano et al. 1998; Herzberg et al. 1997; Lichtman and Martin 1991; Martin et al. 1993, 1998; Mazzari et al. 1996; Meng et al. 1998; Richardson et al. 1998a,b; Smith et al. 1998; Strangman et al. 1998; Tsou et al. 1996; Vivian et al. 1998; Welch et al. 1998).”
BackgroundThe cerebellum: organization, functions and its role in nociception
Saab, C. Y., & Willis, W. D. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00151-6 · Cited by 173
Fibromyalgia: Recent Advances in Diagnosis, Classification, Pharmacotherapy and Alternative Remedies
Maffei, M. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217877 · Cited by 150
“The major active constituent of Cannabis, ∆9-THC (1), has been shown to possess antinociceptive properties when assessed in several experimental models [168] (see also the discussion above on cannabinoids).”
BackgroundUnderstanding the Molecular Aspects of Tetrahydrocannabinol and Cannabidiol as Antioxidants
Borges, R. S., Batista, J., Viana, R. B., Gonçalves, A. C. B., Orestes, E., de Andrade, M. A., Honório, K. M., & da Silva, A. B. F. (2013) · Molecules · doi:10.3390/molecules181012663 · Cited by 162
“Similarly, the activation of the lipase by exogenous ligands of cannabinoid receptors, particularly CB1, induces antinociception in various acute pain tests in rodents [2,4,5], but also in several animal models of chronic pain [6].”
BackgroundDebbarma, G., & Acharya, P. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15489-8.00002-5 · Cited by 148
The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat
Price, T. J., Helesic, G., Parghi, D., Hargreaves, K., & Flores, C. M. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00333-6 · Cited by 144
“While there is ample evidence for antinociceptive effects of cannabinoids in the CNS (Lichtman and Martin, 1991; Martin et al., 1993, 1995; Smith et al., 1994; Hohmann et al., 1995; Lichtman et al., 1996; Meng et al., 1998), there is a growing body of work indicating that cannabinoid antinociception also may be mediat…”
BackgroundAbsence of Δ-9-Tetrahydrocannabinol Dysphoric Effects in Dynorphin-Deficient Mice
Zimmer, A., Valjent, E., König, M., Zimmer, A. M., Robledo, P., Hahn, H., Valverde, O., & Maldonado, R. J. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09499.2001 · Cited by 141
“…effects of intrathecally administered THC (Welch, 1993; Reche et al., 1996; Pugh et al., 1997; Mason et al., 1999), other studies using opioid antagonists did not support an involvement of opioid receptors in cannabinoid analgesia (Martin, 1985; Calignano et al., 1998; Meng et al., 1998).”
BackgroundCannabinoids and autoimmune diseases: A systematic review
Katchan, V., David, P., & Shoenfeld, Y. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.02.008 · Cited by 169
Vaughan, C. W., McGregor, I. S., & Christie, M. J. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702636 · Cited by 137
“The rostral ventromedial medulla (RVM) is thought to be critical for the supraspinal antinociceptive actions of both opioids and cannabinoids (Fields et al., 1991; Martin et al., 1998; Meng et al., 1998).”
BackgroundInfluentialThe neurobiology of cannabinoid analgesia
Walker, J. M., Hohmann, A. G., Martin, W. J., Strangman, N. M., Huang, S. M., & Tsou, K. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00289-1 · Cited by 134
Self-citationda Silva, K. A. B. S., Paszcuk, A. F., Passos, G. F., da Silva, E. S., Bento, A. F., Meotti, F. C., & Calixto, J. Β. (2011) · Pain · doi:10.1016/j.pain.2011.04.005 · Cited by 147
“Studies in neuropathic and inflammatory pain have demonstrated that the activation of both CB1R and CB2R confers a valuable protection against persistent pain [19,41,46].”
BackgroundNeff, G. W., OʼBrien, C., Reddy, K. R., Bergasa, N. V., Regev, A., Molina, E. G., Amaro, R., Rodriguez, M. J., Chase, V., Jeffers, L. J., et al. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05852.x · Cited by 134
Amygdala activity contributes to the dissociative effect of cannabis on pain perception
Lee, M., Ploner, M., Wiech, K., Bingel, U., Wanigasekera, V., Brooks, J. C. W., Menon, D. K., & Tracey, I. (2012) · Pain · doi:10.1016/j.pain.2012.09.017 · Cited by 155
“Evidence from rodent studies suggests that cannabinoid analgesia involves activation of the brainstem circuitry for the descending inhibition of nociception via the amygdala [42,44].”
Hohmann, A. G., Tsou, K., & Walker, J. M. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.81.2.575 · Cited by 128
Down-regulation of anandamide hydrolase in mouse uterus by sex hormones
Maccarrone, M., Felici, M. D., Bari, M., Klinger, F. G., Siracusa, G., & Finazzi‐Agrò, A. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2000.01316.x · Cited by 124
“They mimic the psychotropic, hypnotic, tranquilizing, antiemetic, anticonvulsive and analgesic effects of cannabinoids [5,6].”
BackgroundAntinociceptive, subjective and behavioral effects of smoked marijuana in humans
Greenwald, M. K., & Stitzer, M. L. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00128-3 · Cited by 131
“Recent studies also implicate brainstem circuitry that mediates THC, but not morphine, analgesia (Martin et al., 1998; Meng et al., 1999).”
BackgroundBraida, D., Pozzi, M., Parolaro, D., & Sala, M. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00766-x · Cited by 118
Nieto, M. M., Pommier, B., Tzavara, E. T., Caneparo, A., Nascimento, S. D., Fur, G. L., Roques, B. P., & Noble, F. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703990 · Cited by 122
“Moreover, several lines of evidence support the occurrence of interactions between both systems (Welch et al., 1995; Tanda et al., 1997; Meng et al., 1998; Ambrosio et al., 1999; reviews in Manzanares et al., 1999; Piomelli et al., 2000).”
BackgroundMarijuana and Medicine: Assessing the Science Base
Institute of Medicine (1999) · National Academies Press eBooks · doi:10.17226/6376 · Cited by 270
Cannabinoids modulate pain by multiple mechanisms of action
Richardson, J. D. (2000) · The Journal of Pain · doi:10.1016/s1526-5900(00)90082-8 · Cited by 109
Lever, I. J., & Rice, A. S. C. (2007) · Springer eBooks · doi:10.1007/978-3-540-33823-9_10 · Cited by 115
Hohmann, A. G., Tsou, K., & Walker, J. M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00802-7 · Cited by 112
Metabotropic and NMDA glutamate receptors participate in the cannabinoid-induced antinociception
Palazzo, E., Marabese, I., de Novellis, V., Oliva, P., Rossi, F., Berrino, L., Rossi, F., & Maione, S. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00160-x · Cited by 107
Costa, B., Trovato, A. E., Colleoni, M., Giagnoni, G., Zarini, E., & Croci, T. (2005) · Pain · doi:10.1016/j.pain.2005.03.043 · Cited by 104
“In fact, while the most of studies reported an intrinsic hyperalgesic effect of SR141716 in rats (Chapman, 1999; Herzberg et al., 1997; Meng et al., 1998; Strangman et al., 1998), other studies failed to find such activity in murine pain models (Rinaldi-Carmona et al.”
BackgroundSuplita, R. L., Farthing, J. N., Gutierrez, T., & Hohmann, A. G. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.07.007 · Cited by 115
Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat
Beaulieu, P., Bisogno, T., Punwar, S., Farquhar-Smith, W. P., Ambrosino, G., Marzo, V. D., & Rice, A. S. C. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00226-0 · Cited by 110
Akerman, S., Holland, P. R., Lasalandra, M. P., & Goadsby, P. J. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0943-13.2013 · Cited by 110
“Endocannabinoids are involved in this process, through activation of the CB1 receptor, and descending modulation of nociceptive neuronal firing at the spinal level (Meng et al., 1998; Palazzo et al., 2001; Finn et al., 2003; Meng and Johansen, 2004; Maione et al., 2006).”
BackgroundLa Rana, G., Russo, R., Campolongo, P., Bortolato, M., Mangieri, R. A., Cuomo, V., Iacono, A., Raso, G. M., Meli, R., Piomelli, D., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.100792 · Cited by 97
“In animals, systemic or intracerebral administration of cannabinoid agonists produces profound antinociceptive effects and suppresses activity in CB1-expressing nociceptive neurons of the thalamus, midbrain, and brainstem (Hohmann et al., 1995, 1999, 2005; Meng et al., 1998).”
BackgroundDynamic Regulation of the Endocannabinoid System: Implications for Analgesia
Sagar, D. R., Gaw, A. G., Okine, B. N., Woodhams, S. G., Wong, A., Kendall, D. A., & Chapman, V. (2009) · Molecular Pain · doi:10.1186/1744-8069-5-59 · Cited by 110
“Supra-spinal CB1 receptors, in a number of discrete brain regions, make an important contribution to the antinociceptive effects of cannabinoids in models of acute/tonic pain [44-49].”
BackgroundAlba, R. G., Barragán‐Iglesias, P., González‐Hernández, A., Valdez-Moráles, E. E., Granados‐Soto, V., Condés‐Lara, M., Rodríguez, M. G., & Marichal‐Cancino, B. A. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01496 · Cited by 106
Survey of cannabis use in patients with amyotrophic lateral sclerosis
Amtmann, D., Weydt, P., Johnson, K. L., Jensen, M. P., & Carter, G. T. (2004) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/104990910402100206 · Cited by 106
Experience with the Synthetic Cannabinoid Nabilone in Chronic Noncancer Pain
Berlach, D. M., Shir, Y., & Ware, M. A. (2006) · Pain Medicine · doi:10.1111/j.1526-4637.2006.00085.x · Cited by 96
The rodent amygdala contributes to the production of cannabinoid-induced antinociception
Manning, B. H., Martin, W. J., & Meng, I. D. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00356-7 · Cited by 105
Self-citationEffects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation
Pistis, M., Porcu, G. S., Melis, M., Diana, M., & Gessa, G. L. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01612.x · Cited by 100
“Cannabinoids produce a large number of CB1 receptor-mediated effects, including analgesia (Meng et al., 1998; Richardson et al., 1998), hypomotility (Crawley et al., 1993), catalepsy (Prescott et al., 1992; Compton et al., 1996), cognitive de®cits (Nakamura et al., 1991; Lichtman et al., 1995;…”
BackgroundManning, B. H., Merin, N. M., Meng, I. D., & Amaral, D. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-20-08238.2001 · Cited by 88
“Furthermore, like morphine-induced antinociception, cannabinoid-induced antinociception is reduced by inactivation of RVM neurons and is correlated with activation of a class of pain-modulating neurons in the RVM referred to as the OFF cell (Meng et al., 1998).”
BackgroundResultSelf-citationLal, S., Shekher, A., Puneet, Narula, A. S., Abrahamse, H., & Gupta, S. C. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105302 · Cited by 97
The Role of the Brain's Endocannabinoid System in Pain and Its Modulation by Stress
Corcoran, L., Roche, M., & Finn, D. P. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.10.003 · Cited by 94
“Millan, M. J. (1999). The induction of pain: an integrative review. Prog Neurobiol, 57(1), 1164. Mohammad-Pour Kargar, H., Azizi, H., Mirnajafi-Zadeh, J., Reza Mani, A., & Semnanian, S. (2015). Microinjection of orexin-A into the rat locus coeruleus nucleus induces analgesia via cannabinoid type-1 receptors. Brain Res…”
BackgroundInfluential
Metadata
- Authors
- Meng, I. D., Manning, B. H., Martin, W. J., & Fields, H. L.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Meng, Ian D.
- Venue
- Nature
- Published
- 1998-09
- Volume
- 395
- Issue
- 6700
- Pages
- 381-383
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1645449597
- Cited by
- 411
- References
- 30
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 8 · 2023: 8 · 2022: 8 · 2021: 18 · 2020: 13 · 2019: 11 · 2018: 5 · 2017: 11 · 2016: 12 · 2015: 10 · 2014: 13 · 2013: 12 · 2012: 15
- FWCI
- 17.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- cannabinoid analgesia, delta-9-tetrahydrocannabinol, rostral ventromedial medulla, morphine analgesia, endocannabinoids, motor impairment, opioid analgesia
- MeSH terms
- Rimonabant, Analgesia, Animals, Cannabinoids, Male, Medulla Oblongata, Morphine, Morpholines, Motor Activity, Muscimol, Naphthalenes, Neural Pathways, Neurons, Piperidines, Pyrazoles, Receptors, Drug, Rats, Sprague-Dawley, Analgesics, Non-Narcotic, GABA Agonists, Receptors, Cannabinoid, Benzoxazines, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.